The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...
Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Medicare bills are increasing for millions of Americans despite a $2,000 prescription drug cap beginning in 2025, as premiums ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Nearly 3 million Americans are poised to see bigger Social Security benefit checks. For some, that could trigger larger tax ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Health insurance companies selling private Medicare Advantage plans in the US would see a greater increase in payments in ...
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...